These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25634646)

  • 1. Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study.
    Besser AG; Sanderson SC; Roberts JS; Chen CA; Christensen KD; Lautenbach DM; Cupples LA; Green RC
    Public Health Genomics; 2015; 18(2):78-86. PubMed ID: 25634646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.
    Eckert SL; Katzen H; Roberts JS; Barber M; Ravdin LD; Relkin NR; Whitehouse PJ; Green RC
    Genet Med; 2006 Dec; 8(12):746-51. PubMed ID: 17172937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disclosure of APOE genotype for risk of Alzheimer's disease.
    Green RC; Roberts JS; Cupples LA; Relkin NR; Whitehouse PJ; Brown T; Eckert SL; Butson M; Sadovnick AD; Quaid KA; Chen C; Cook-Deegan R; Farrer LA;
    N Engl J Med; 2009 Jul; 361(3):245-54. PubMed ID: 19605829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.
    Cassidy MR; Roberts JS; Bird TD; Steinbart EJ; Cupples LA; Chen CA; Linnenbringer E; Green RC
    Alzheimers Dement; 2008 Nov; 4(6):406-13. PubMed ID: 19012865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.
    Linnenbringer E; Roberts JS; Hiraki S; Cupples LA; Green RC
    Genet Med; 2010 Apr; 12(4):219-27. PubMed ID: 20139767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attitudes towards predictive genetic testing for Alzheimer's disease].
    Illes F; Bernhardt T; Prell K; Rietz C; Rudinger G; Frölich L; Maier W; Rietschel M
    Z Gerontol Geriatr; 2006 Jun; 39(3):233-9. PubMed ID: 16794889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.
    Christensen KD; Roberts JS; Whitehouse PJ; Royal CD; Obisesan TO; Cupples LA; Vernarelli JA; Bhatt DL; Linnenbringer E; Butson MB; Fasaye GA; Uhlmann WR; Hiraki S; Wang N; Cook-Deegan R; Green RC;
    Ann Intern Med; 2016 Feb; 164(3):155-63. PubMed ID: 26810768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.
    Roberts JS; Chen CA; Uhlmann WR; Green RC
    Genet Med; 2012 Aug; 14(8):742-8. PubMed ID: 22498844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using ApoE Genotyping to Promote Healthy Lifestyles in Finland - Psychological Impacts: Randomized Controlled Trial.
    Hietaranta-Luoma HL; Luomala HT; Puolijoki H; Hopia A
    J Genet Couns; 2015 Dec; 24(6):908-21. PubMed ID: 25735442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
    Roberts JS; Cupples LA; Relkin NR; Whitehouse PJ; Green RC;
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):250-5. PubMed ID: 16306249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.
    Green RC; Christensen KD; Cupples LA; Relkin NR; Whitehouse PJ; Royal CD; Obisesan TO; Cook-Deegan R; Linnenbringer E; Butson MB; Fasaye GA; Levinson E; Roberts JS;
    Alzheimers Dement; 2015 Oct; 11(10):1222-30. PubMed ID: 25499536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of genetic testing for risk of Alzheimer's disease.
    Kane RA; Kane RL
    N Engl J Med; 2009 Jul; 361(3):298-9. PubMed ID: 19605835
    [No Abstract]   [Full Text] [Related]  

  • 15. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.
    Levy JA; Bergeson J; Putnam K; Rosen V; Cohen R; Lalonde F; Mirza N; Linker G; Sunderland T
    J Int Neuropsychol Soc; 2004 May; 10(3):362-70. PubMed ID: 15147594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.
    Cupples LA; Farrer LA; Sadovnick AD; Relkin N; Whitehouse P; Green RC
    Genet Med; 2004; 6(4):192-6. PubMed ID: 15266206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study.
    Guan Y; Roter DL; Erby LH; Wolff JL; Gitlin LN; Roberts JS; Green RC; Christensen KD
    Patient Educ Couns; 2017 May; 100(5):927-935. PubMed ID: 28012682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive genetic testing for Alzheimer's disease: impact upon risk perception.
    Marteau TM; Roberts S; LaRusse S; Green RC
    Risk Anal; 2005 Apr; 25(2):397-404. PubMed ID: 15876213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disclosure of the genetic risk of Alzheimer's disease.
    Gordon SC; Landa D
    N Engl J Med; 2010 Jan; 362(2):181-2; author reply 182. PubMed ID: 20071713
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of brain activation in people at risk for Alzheimer's disease.
    Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
    N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.